Al Issa A - Search Results

1

Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.

Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T, Katayama I, Anbar T, Abdallah M, Benzekri L, Gauthier Y, Harris J, Silva de Castro CC, Pandya A, Goh BK, Lan CC, Oiso N, Al Issa A, Esmat S, Le Poole C, Lee AY, Parsad D, Taieb A, Picardo M, Ezzedine K; Vitiligo Global Issues Consensus Group. Eleftheriadou V, et al. Among authors: al issa a. Pigment Cell Melanoma Res. 2015 May;28(3):363-9. doi: 10.1111/pcmr.12354. Epub 2015 Feb 13. Pigment Cell Melanoma Res. 2015. PMID: 25645179 No abstract available.

2

Hypochromic vitiligo: delineation of a new entity.

Ezzedine K, Mahé A, van Geel N, Cardot-Leccia N, Gauthier Y, Descamps V, Al Issa A, Ly F, Chosidow O, Taïeb A, Passeron T. Ezzedine K, et al. Among authors: al issa a. Br J Dermatol. 2015 Mar;172(3):716-21. doi: 10.1111/bjd.13423. Epub 2014 Dec 11. Br J Dermatol. 2015. PMID: 25255745

3

Six-year follow-up of vitiligo patients successfully treated with autologous non-cultured melanocyte-keratinocyte transplantation.

Altalhab S, AlJasser MI, Mulekar SV, Al Issa A, Mulekar S, Diaz J, Diallo A, Ezzedine K. Altalhab S, et al. Among authors: al issa a. J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1172-1176. doi: 10.1111/jdv.15411. Epub 2019 Feb 22. J Eur Acad Dermatol Venereol. 2019. PMID: 30793805

4

Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.

Isedeh P, Al Issa A, Lim HW, Mulekar SS, Mulekar SV. Isedeh P, et al. Among authors: al issa a. J Cutan Med Surg. 2015 Mar-Apr;19(2):177-81. doi: 10.2310/7750.2014.14061. Epub 2015 Mar 11. J Cutan Med Surg. 2015. PMID: 25775633

5

Mixed vitiligo.

Mulekar SV, Al Issa A, Asaad M, Ghwish B, Al Eisa A. Mulekar SV, et al. Among authors: al eisa a, al issa a. J Cutan Med Surg. 2006 Mar-Apr;10(2):104-7. doi: 10.2310/7750.2006.00018. J Cutan Med Surg. 2006. PMID: 17241584

6

Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation.

Al Jasser MI, Ghwish B, Al Issa A, Mulekar SV. Al Jasser MI, et al. Among authors: al issa a. Int J Dermatol. 2013 Nov;52(11):1383-6. doi: 10.1111/ijd.12134. Epub 2013 Jul 8. Int J Dermatol. 2013. PMID: 23834588

7

Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study.

Mulekar SV, Ghwish B, Al Issa A, Al Eisa A. Mulekar SV, et al. Among authors: al eisa a, al issa a. Br J Dermatol. 2008 Jan;158(1):45-9. doi: 10.1111/j.1365-2133.2007.08216.x. Epub 2007 Oct 10. Br J Dermatol. 2008. PMID: 17927795

8

Genital vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.

Mulekar SV, Al Issa A, Al Eisa A, Asaad M. Mulekar SV, et al. Among authors: al eisa a, al issa a. Dermatol Surg. 2005 Dec;31(12):1737-9; discussion 1740. doi: 10.2310/6350.2005.31324. Dermatol Surg. 2005. PMID: 16336903

9

Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.

Mulekar SV, Al Issa A, Al Eisa A. Mulekar SV, et al. Among authors: al eisa a, al issa a. Dermatol Surg. 2009 Jan;35(1):66-71. doi: 10.1111/j.1524-4725.2008.34384.x. Epub 2008 Dec 8. Dermatol Surg. 2009. PMID: 19076191

10

Childhood vitiligo: a long-term study of localized vitiligo treated by noncultured cellular grafting.

Mulekar SV, Al Eisa A, Delvi MB, Al Issa A, Al Saeed AH. Mulekar SV, et al. Among authors: al eisa a, al issa a, al saeed ah. Pediatr Dermatol. 2010 Mar-Apr;27(2):132-6. doi: 10.1111/j.1525-1470.2009.00978.x. Epub 2009 Oct 4. Pediatr Dermatol. 2010. PMID: 19804496

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters